Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
作者信息
Amid Ali, Chen Shiyi, Athale Uma, Charpentier Karen, Merelles-Pulcini Manuela, Odame Isaac, Kirby-Allen Melanie
机构信息
Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON
Department of Pediatrics, University of Ottawa, Ottawa, ON.
出版信息
Haematologica. 2018 May;103(5):e184-e187. doi: 10.3324/haematol.2017.178368. Epub 2018 Jan 25.
Abstract
摘要
相似文献
1
Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
Haematologica. 2018 May;103(5):e184-e187. doi: 10.3324/haematol.2017.178368. Epub 2018 Jan 25.
2
Outcomes of haemoglobin Bart's hydrops fetalis following intrauterine transfusion in Ontario, Canada.
Arch Dis Child Fetal Neonatal Ed. 2021 Jan;106(1):51-56. doi: 10.1136/archdischild-2019-317626. Epub 2020 Jul 2.
3
Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
Br J Haematol. 2022 May;197(3):373-376. doi: 10.1111/bjh.18077. Epub 2022 Feb 17.
4
Prenatal eradication of Hb Bart's hydrops fetalis.
J Reprod Med. 2001 Jan;46(1):18-22.
5
Characterization of Hb Bart's Hydrops Fetalis Caused by - - and a Large Novel α-Thalassemia Deletion.
Hemoglobin. 2018 Jan;42(1):61-64. doi: 10.1080/03630269.2018.1434198. Epub 2018 Mar 1.
6
Hemoglobin Bart's hydrops fetalis: charting the past and envisioning the future.
Blood. 2024 Aug 22;144(8):822-833. doi: 10.1182/blood.2023023692.
7
Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis.
Blood. 2016 Mar 3;127(9):1208-11. doi: 10.1182/blood-2015-10-673889. Epub 2016 Jan 5.
8
Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.
Reprod Biomed Online. 2010 Nov;21(5):642-8. doi: 10.1016/j.rbmo.2010.06.021. Epub 2010 Jun 19.
9
Outcome of survivors with hemoglobin Bart's hydrops fetalis syndrome: The most severe form of α-thalassemia.
Pediatr Transplant. 2021 Nov;25(7):e14090. doi: 10.1111/petr.14090. Epub 2021 Jul 13.
10
Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment.
J Matern Fetal Neonatal Med. 2018 Apr;31(7):946-957. doi: 10.1080/14767058.2017.1301423. Epub 2017 Mar 21.
引用本文的文献
1
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.
Blood. 2024 Oct 10;144(15):1633-1645. doi: 10.1182/blood.2023023349.
2
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis.
Haematologica. 2023 Oct 1;108(10):2582-2593. doi: 10.3324/haematol.2023.283057.
3
Challenges in chronic transfusion for patients with thalassemia.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):160-166. doi: 10.1182/hematology.2020000102.
本文引用的文献
1
An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
Blood. 2017 Mar 9;129(10):1251-1259. doi: 10.1182/blood-2016-08-697110. Epub 2017 Jan 5.
2
HbH Constant Spring disease has lower serum ferritin relative to liver iron concentration (LIC): importance of LIC measurement and potential impact on serum ferritin thresholds for iron chelation.
Br J Haematol. 2017 Mar;176(6):986-988. doi: 10.1111/bjh.14013. Epub 2016 Mar 15.
3
Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis.
Blood. 2016 Mar 3;127(9):1208-11. doi: 10.1182/blood-2015-10-673889. Epub 2016 Jan 5.
4
Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
Blood. 2015 Jan 29;125(5):873-80. doi: 10.1182/blood-2014-10-606491. Epub 2014 Dec 17.
5
Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Blood. 2013 Jul 4;122(1):124-33. doi: 10.1182/blood-2012-12-471441. Epub 2013 May 8.
6
Iron metabolism: interactions with normal and disordered erythropoiesis.
Cold Spring Harb Perspect Med. 2012 May;2(5):a011668. doi: 10.1101/cshperspect.a011668.
7
The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders.
Hematology Am Soc Hematol Educ Program. 2011;2011:538-42. doi: 10.1182/asheducation-2011.1.538.
8
Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
Haematologica. 2008 Oct;93(10):1584-6. doi: 10.3324/haematol.13098. Epub 2008 Aug 25.
9
Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pediatr Blood Cancer. 2007 Sep;49(3):329-32. doi: 10.1002/pbc.21275.
10
Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Haematologica. 2007 May;92(5):583-8. doi: 10.3324/haematol.10842.
Zotero 插件